NorthStar Medical Radioisotopes Revenue and Competitors

Beloit, WI USA

Location

$117.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • NorthStar Medical Radioisotopes's estimated annual revenue is currently $93.1M per year.(i)
  • NorthStar Medical Radioisotopes's estimated revenue per employee is $281,400
  • NorthStar Medical Radioisotopes's total funding is $117.5M.

Employee Data

  • NorthStar Medical Radioisotopes has 331 Employees.(i)
  • NorthStar Medical Radioisotopes grew their employee count by 25% last year.

NorthStar Medical Radioisotopes's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
SVP, Chief Regulatory OfficerReveal Email/Phone
3
SVP and Chief Technology OfficerReveal Email/Phone
4
VP Advanced Radioisotopes and Therapeutic TechnologiesReveal Email/Phone
5
VP, Corporate Development and External AffairsReveal Email/Phone
6
VP Quality AffairsReveal Email/Phone
7
VP, Business Development Advanced Radioisotopes & Therapeutic TechnologiesReveal Email/Phone
8
VP, Chief StaffReveal Email/Phone
9
VP OperationsReveal Email/Phone
10
VP, Manufacturing & Customer SupportReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.2M41-7%N/AN/A
#2
$71M35323%N/AN/A
#3
$36.2M1805%N/AN/A
#4
$36M17923%N/AN/A
#5
$99.7M496N/AN/AN/A
#6
$3.4M176%N/AN/A
#7
$12.7M632%N/AN/A
#8
$5.4M2713%N/AN/A
#9
$10.3M516%N/AN/A
#10
$0.8M40%N/AN/A
Add Company

What Is NorthStar Medical Radioisotopes?

NorthStar® Medical Radioisotopes is a nuclear medicine technology company dedicated to transforming the ways that medical radioisotopes are produced and distributed around the world. We are committed to providing the United States with reliable and environmentally friendly radioisotope supply solutions to meet the needs of patients and to advance clinical research. Our first product is the FDA-approved RadioGenix® System, a first of its kind, innovative platform technology for the processing of domestically sourced molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), which is currently the most widely used diagnostic radioisotope for medical purposes. Based in Beloit, Wis., NorthStar Medical Radioisotopes, LLC is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.

keywords:Biotechnology,Healthcare,Hospitality,Medical Devices,Pharmaceuticals

$117.5M

Total Funding

331

Number of Employees

$93.1M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NorthStar Medical Radioisotopes News

2022-04-17 - Radiopharmaceuticals in Nuclear Medicine Market Detailed In New Research Report 2022 | Progenics Pharmaceutica

... in Nuclear Medicine Market Detailed In New Research Report 2022 | Progenics Pharmaceuticals, Inc., NorthStar Medical Radioisotopes LLC,...

2022-04-06 - Global Demand of Radiopharmaceutical Market Size & Share ...

... and strategies are Eczacýbaþý-Monrol Nuclear Products, NorthStar Medical Radioisotopes, Smith & Nephew plc., Lantheus Medical Imaging,...

2022-03-22 - NorthStar Medical Radioisotopes Provides Updates on ...

NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$91.1M34734%N/A
#2
$204.5M6065%N/A
#3
$145.6M6475%N/A
#4
$522.3M7780%$1.8B
#5
$323.9M85710%N/A